Tranexamic Acid In Sodium Chloride Injection, Solution
Product Images NDC 65219-534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid In Sodium Chloride (NDC 65219-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tra19 0001 01)

FDA Label Image

Fresenius Kabi Logo (Tra19 0001 02)

FDA Label Image

Trane-label-01.jpg (Trane Label 01)

Trane-label-01.jpg (Trane Label 01)
Product No. 534110 is a single-dose container with Tranexamic Acid in 0.7% Dicird Ukussd Rertises Sodium Chloride Injection. Each container contains 100 mL with a dosage of 1,000 mg per 100 mL. It should only be used for intravenous infusion and not as a supplemental medication. The solution has a pH range of 6.5 to 8.0 and should be stored at a temperature of 20°C to 25°C. The expiration date is specified as YYYY-MM with Lot number 0000000. For dosage information, refer to the prescribing information.*
FDA Label Image

Trane-label-02.jpg (Trane Label 02)

Trane-label-02.jpg (Trane Label 02)
This is a description of a pharmaceutical product containing Tranexamic Acid in 0.7% Sodium Chloride Injection. The container is for intravenous infusion and has a concentration of 1,000 mg per 100 mL. The product is intended for single-use only, and any unused portion should be discarded. It is essential to use the solution immediately after removal from its packaging. The storage conditions are between 20°C to 25°C (68°F to 77°F). The manufacturing company is Fresenius Kabi USA, LLC, and the product is made in Norway. It is indicated to check for leaks in the bag before use and not to use the solution if it is not clear. Supplemental medications should not be added, and the solution should not be used in series connections.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.